Hepatitis A
📧 Sign up to get email alerts when something new happens for Hepatitis A.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of an inactivated Hepatitis A vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients [Phase 4]
Phase 4 trial assessing the effectiveness of a booster dose strategy for Hepatitis A vaccine in HIV-infected individuals.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of an inactivated Hepatitis A vaccine in healthy children aged 24 months to 15 yea…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine [Phase 4]
Phase 4 trial update comparing immunization schedules of inactivated Hepatitis A vaccine with a combined Hepatitis A and B vaccine; study co…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis [Phase 2, Phase 3]
A randomized placebo-controlled trial evaluating safety and efficacy of silymarin in acute viral hepatitis was terminated after Phase 2/3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine [Phase 4]
Phase 4 clinical trial update evaluating safety and immunogenicity of a Hepatitis A vaccine.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine [Phase 3]
Phase 3 trial update showing immunogenicity and safety of co-administering a tetravalent dengue vaccine with a Hepatitis A vaccine in health…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine [Phase 4]
Phase 4 trial update evaluating safety and immunogenicity of measles, varicella, and hepatitis A vaccines.
-
CLINICAL_TRIALS research · 2019-09-23Clinical Trial Update: This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama [NA]
A completed clinical trial assessing long-term persistence of Hepatitis A antibodies in children after Havrix vaccination in Panama, with re…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine [Phase 4]
Phase 4 trial update on safety, immunogenicity, and immune persistence of an inactivated Hepatitis A vaccine.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human) [Phase 4]
Phase 4 trial updates pharmacokinetics and safety of human immune globulin for anti-Hepatitis A antibodies in healthy subjects; results comp…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines [Phase 3]
Clinical trial update reporting long-term follow-up data on safety and immunogenicity of a Hepatitis A vaccine administered with and without…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc [Phase 4]
Phase 4 clinical trial evaluating factors influencing immune response to combined Hepatitis A & B vaccine vs monovalent vaccines; completed …
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel [Phase 4]
A Phase 4 clinical trial evaluating the immunogenicity and persistence of Havrix in healthy adults vaccinated in infancy under Israel's univ…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Comparative Immunogenicity Study of Two Hepatitis A Vaccines [Phase 4]
Phase 4 comparative immunogenicity study of two Hepatitis A vaccines sponsored by China National Biotec Group; the status/results are not pr…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults [Phase 4]
This Phase 4 study reports that the combined Hepatitis A and B vaccine is non-inferior to monovalent vaccines in adults.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age [Phase 3]
A Phase 3 trial evaluating immune response and safety when a Hepatitis A vaccine is given with a pneumococcal vaccine in healthy 15-month-ol…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 2]
Phase 2 safety and immunogenicity study of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity [Phase 3]
A Phase 3 comparative trial in healthy adults evaluates reactogenicity and immunogenicity of Hepatyrix versus Havrix with Typherix or Tiphim…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine [Phase 3]
Long-term follow-up from Phase 3 trials to demonstrate the equivalence of two vaccination schedules for the combined Hepatitis A & B vaccine…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)
Completion of a regulatory post-marketing surveillance study for the Hepatitis A vaccine AVAXIM 160U by Sanofi Pasteur.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children
This document reports the fifth-year follow-up results of a Phase IV Hepatitis A vaccine trial in healthy children, and indicates the study …
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Hepatitis A Vaccination in the Elderly
The clinical trial investigating Hepatitis A vaccination in elderly participants has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Hepatitis A Vaccine in Patients With Immunomodulating Drugs [Phase 2]
Phase 2 clinical trial update evaluating the immune response to a Hepatitis A vaccine in patients taking immunomodulating drugs.
-
CLINICAL_TRIALS withdrawal · 2015-11-18Clinical Trial Update: Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) [Phase 4]
This Phase 4 study evaluating long-term hepatitis A and B antibody persistence in healthy adults previously primed with Twinrix has been wit…